Rocky Mountain Health Plans to cover heavy babies
Discovery of flaw in system leads Rocky Mountain Health Plans to change policy regarding coverage of heavy babies.
Rocky Mountain Health Plans, Grand Junction, Colo., has made a companywide policy change and will now provide health plan coverage for healthy infants, regardless of their weight.
Alex Lange was denied coverage when he was two months old because his height and weight were in the 99th percentile according to Centers for Disease Control and Prevention guidelines. In light of the national healthcare reform debate, news outlets, bloggers and talk show hosts across the country covered the story, showing a healthy-looking Alex and interviewing his frustrated parents.
The situation brought attention to a “flaw in our underwriting program for approving infants,” says Steve ErkenBrack, president and CEO, Rocky Mountain Health Plans. “We have changed our policy, corrected our underwriting guidelines, and are working to notify the parents of the infant who we earlier denied.”
The flaw was attributed to a relatively new trend involving families seeking individual coverage for their children. Underwriting for this age group is a relatively new process, according to Rocky Mountain Health Plans.
“We are constantly working on new, innovative ways to deliver quality, affordable health plans that are designed for the people of Colorado,” says ErkenBrack.
Rocky Mountain Health Plans provides medical benefit plans and services to more than 170,000 enrollees in Colorado.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
July 25th 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More
